Discussion
Children with severe hemophilia B who develop antibodies, also known as inhibitors, against coagulation factor IX (FIX) replacement therapies continue to face major treatment challenges, according to a small study in the U.K. The study found that attempts to eliminate these inhibitors using an approach called immune tolerance induction…